Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Autoinjector is a medical device used to dispense a single dose of a drug, particularly, life-saving drugs. These autoinjectors are usually spring-loaded syringes that are particularly designed for easy and safe administration of the drugs.
The global Autoinjectors market was valued at US$ 26960 million in 2019 and is expected to reach US$ 66710 million by the end of 2026, growing at a CAGR of 13.7% during 2021-2026.
This report focuses on Autoinjectors volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Autoinjectors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Autoinjectors Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Fillable Autoinjectors
Prefilled Autoinjectors
Segment by Application
Rheumatoid Arthritis
Anaphylaxis
Multiple Sclerosis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Antares Pharma
Biogen Idec
Becton Dickinson
Mylan
Pfizer
Novartis International
Unilife
Ypsomed Holdings
Scandinavian Health Limited (SHL)
Sanofi
The global Autoinjectors market was valued at US$ 26960 million in 2019 and is expected to reach US$ 66710 million by the end of 2026, growing at a CAGR of 13.7% during 2021-2026.
This report focuses on Autoinjectors volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Autoinjectors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Autoinjectors Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Fillable Autoinjectors
Prefilled Autoinjectors
Segment by Application
Rheumatoid Arthritis
Anaphylaxis
Multiple Sclerosis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Antares Pharma
Biogen Idec
Becton Dickinson
Mylan
Pfizer
Novartis International
Unilife
Ypsomed Holdings
Scandinavian Health Limited (SHL)
Sanofi
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
